PacBio (PACB) announced it has joined the 1000 Genomes Long Read Sequencing Project, which will involve contributing long-read transcriptome data to one of the world’s most expansive human genomics initiatives. In collaboration with the laboratories of Danny Miller, MD, PhD, Evan Eichler, PhD, at the University of Washington, and Rajiv McCoy, PhD at the McCoy Lab at Johns Hopkins University, PacBio will contribute full-length isoform sequencing using its Kinnex RNA kits and Revio sequencing platform. The collaboration will add Iso-Seq data for approximately 1,000 samples from the 1000 Genomes cohort.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACB:
- Qiagen expands NGS portfolio with launch of QIAseq xHYB Long Read Panels
- PacBio price target lowered to $1.50 from $2 at Barclays
- Largest borrow rate increases among liquid names
- Pacific Biosciences Approves Key Proposals at Annual Meeting
- PacBio partners with Target ALS to launch genome sequencing initiative
